Michel Fardeau

24.7k citations

270 papers · 15.2k indexed · 5 hit papers · h-index 64

Molecular Biology top 0.2%
Cellular and Molecular Neuroscience top 0.2%
Cell Biology top 0.1%
Cardiology and Cardiovascular Medicine top 0.5%
Genetics top 0.2%

Co-authors: F.M.S. Tomé Pascale Guicheney Norma B. Romero B. Eymard J. Beckmann Ketty Schwartz Danielle Château Fernando Tomé
Topics: Muscle Physiology and Disorders (139 papers)Genetic Neurodegenerative Diseases (50 papers)Cardiomyopathy and Myosin Studies (48 papers)
Cited by: Cell Biology Cellular and Molecular Neuroscience Molecular Biology
Journals: Nature New England Journal of Medicine Cell
Partner nations: France United States Germany

In The Last Decade

Michel Fardeau

265 papers receiving 14.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy

1999 1.0k citations Gisèle Bonne, Marina Raffaele di Barletta et al. Nature Genetics profile →
A missense mutation in the αB-crystallin chaperone gene causes a desmin-related myopathy

1998 866 citations Patrick Vicart, Anne Caron et al. Nature Genetics profile →
Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A

1995 774 citations Michel Fardeau et al. profile →
Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy

1998 583 citations F.M.S. Tomé, Michel Fardeau et al. Nature Genetics profile →
Mutations in the laminin α2–chain gene (LAMA2) cause merosin–deficient congenital muscular dystrophy

1995 506 citations Haluk Topaloğlu, F.M.S. Tomé et al. Nature Genetics profile →

Peers

Countries citing papers authored by Michel Fardeau

Since Specialization

Citations

This map shows the geographic impact of Michel Fardeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Fardeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Fardeau more than expected).

Fields of papers citing papers by Michel Fardeau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Fardeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Fardeau. The network helps show where Michel Fardeau may publish in the future.

Co-authorship network of co-authors of Michel Fardeau

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Fardeau. A scholar is included among the top collaborators of Michel Fardeau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Fardeau. Michel Fardeau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ACTN2 mutations cause “Multiple structured Core Disease” (MsCD) 2019 ·Acta Neuropathologica ·Xavière Lornage,Norma B. Romero,(unknown),(unknown),Sandra Donkervoort,(unknown),Sarah Neuhaus,A. Reghan Foley,C. Labasse,Raphaël Schneider,Robert Carlier,Katherine R. Chao,Līvija Medne,Jean‐François Deleuze,David Orlikowski,Carsten G. Bönnemann,Vandana Gupta,Michel Fardeau,Johann Böhm,Jocelyn Laporte	35
2	Genetic Mutations and Demographic, Clinical, and Morphological Aspects of Myofibrillar Myopathy in a French Cohort 2018 ·Genetic Testing and Molecular Biomarkers ·Alzira Alves de Siqueira Carvalho,(unknown),Guy Brochier,(unknown),(unknown),(unknown),(unknown),Konstantinos Papadopoulos,Anthony Béhin,Pascal Laforêt,T. Stojkovic,B. Eymard,Michel Fardeau,Norma B. Romero	16
3	Syndromes myasthéniques congénitaux — L’expérience française 2014 ·Bulletin de l Académie Nationale de Médecine ·B. Eymard,Daniel Hantaı̈,Emmanuel Fournier,Sophie Nicole,Damien Sternberg,Pascale Richard,Michel Fardeau	1
4	Recessive RYR1 mutations cause unusual congenital myopathy with prominent nuclear internalization and large areas of myofibrillar disorganization 2010 ·Neuropathology and Applied Neurobiology ·Jorge A. Bevilacqua,Nicole Monnier,Marc Bitoun,B. Eymard,Ana Ferreiro,Soledad Monges,(unknown),(unknown),A. Laquérrière,Kristl G. Claeys,Isabelle Marty,Michel Fardeau,Pascale Guicheney,Joël Lunardi,Norma B. Romero	75
5	121st ENMC International Workshop on Desmin and Protein Aggregate Myopathies. 7–9 November 2003, Naarden, The Netherlands 2004 ·Neuromuscular Disorders ·(unknown),Michel Fardeau	20
6	Genetic characterisation of multi-minicore disease: identification of a first locus and evidence for genetic heterogeneity 2001 ·UCL Discovery (University College London) ·Ana Ferreiro,B. Estournet,C Laroche,(unknown),(unknown),(unknown),Nathalie Goemans,Heinz Jungbluth,(unknown),Luciano Merlini,Haluk Topaloğlu,T. Voit,Michel Fardeau,Pascale Guicheney	1
7	Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophybreakdown → 1999 ·Nature Genetics ·Gisèle Bonne,Marina Raffaele di Barletta,Shaïda Varnous,Henri-Marc Bécane,E. Hammouda,Luciano Merlini,Francesco Muntoni,Cheryl R. Greenberg,Françoise Gary,J.A. Urtizberea,Denis Duboc,Michel Fardeau,Daniela Toniolo,Ketty Schwartz	1032
8	Hereditary inclusion body myopathies 1998 ·Current Opinion in Neurology ·(unknown),Michel Fardeau	10
9	A missense mutation in the αB-crystallin chaperone gene causes a desmin-related myopathybreakdown → 1998 ·Nature Genetics ·Patrick Vicart,Anne Caron,Pascale Guicheney,Zhenlin Li,(unknown),(unknown),Danielle Château,Françoise Chapon,Fernando Tomé,Jean-Marie Dupret,Denise Paulin,Michel Fardeau	866
10	Human desmin gene: cDNA sequence, regional localization and exclusion of the locus in a familial desmin-related myopathy 1996 ·Human Genetics ·Patrick Vicart,Jean‐Marie Dupret,Jamïlé Hazan,Zhenlin Li,Gàbor Gyapay,(unknown),Jean Weissenbach,Michel Fardeau,Denise Paulin	52
11	Absence of γ‐sarcoglycan (35 DAG) in autosomal recessive muscular dystrophy linked to chromosome 13q12 1996 ·FEBS Letters ·Daniel Jung,France Leturcq,Yoshihide Sunada,Franck Duclos,F.M.S. Tomé,Carolyn R. Moomaw,Luciano Merlini,K. Azibi,Malika Chaouch,Clive A. Slaughter,Michel Fardeau,(unknown),Kevin P. Campbell	46
12	Expression of dystrophin-associated glycoproteins during human fetal muscle development: A preliminary immunocytochemical study 1994 ·Neuromuscular Disorders ·F.M.S. Tomé,Kiichiro Matsumura,M. Chevallay,Kevin P. Campbell,Michel Fardeau	40
13	Deficiency of dystrophin-associated proteins in Duchenne muscular dystrophy patients lacking COOH-terminal domains of dystrophin. 1993 ·Journal of Clinical Investigation ·Kiichiro Matsumura,F.M.S. Tomé,Victor Ionâşescu,James M. Ervasti,Richard D. Anderson,Norma B. Romero,Dávid Simon,Dominique Récan,J.‐C. Kaplan,Michel Fardeau	60
14	Social identity and the International Classification of Handicaps: An evaluation of the consequences of facioscapulohumeral muscular dystrophy 1992 ·Disability and Rehabilitation ·Isabelle Ville,Jean‐François Ravaud,Francis Marchal,(unknown),Michel Fardeau	13
15	[Recollections on the centenary of the death of Vulpian (5 January 1826-18 May 1887)]. 1988 ·PubMed ·Michel Fardeau	2
16	Physical state abnormality of erythrocyte membrane in myotonic dystrophy: a spin label study 1987 ·Clinica Chimica Acta ·(unknown),(unknown),Denis Daveloose,Jacques Viret,Michel Fardeau,F Leterrier	4
17	Myopathie lipidique avec cardiomyopathie sévère par déficit généralisé en carnitine. Evolution favorable sous un traitement par chlorhydrate de carnitine. 1979 ·Archives Des Maladies Du Coeur Et Des Vaisseaux ·Pierre Morand,F Despert,H Carrier,(unknown),Michel Fardeau,(unknown),(unknown),Pierre Combe	3
18	[Centromuclear myopathy with late clinical manifestations. Clinical, histological and ultrastructural study of a new case]. 1976 ·PubMed ·M Goulon,Michel Fardeau,(unknown),P Babinet,(unknown)	10
19	Ultrastructure des fibres musculaires squelettiques. II. 1969 ·La Presse Médicale ·Michel Fardeau	4
20	The Central Nervous System and Carbon Monoxide Poisoning II. Anatomical Study of Brain Lesions following Intoxication with Carbon Monoxide (22 cases) 1967 ·Progress in brain research ·J Lapresle,Michel Fardeau	141

About Michel Fardeau

Michel Fardeau is a scholar working on Clinical Biochemistry, Cell Biology and Cellular and Molecular Neuroscience, having authored 270 papers that have together received 15.2k indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (139 papers), Genetic Neurodegenerative Diseases (50 papers) and Cardiomyopathy and Myosin Studies (48 papers). The work is most often cited by research in Cell Biology (3.5k citations), Cellular and Molecular Neuroscience (3.7k citations) and Molecular Biology (12.0k citations). Michel Fardeau has collaborated with scholars based in France, United States and Germany. Frequent co-authors include F.M.S. Tomé, Pascale Guicheney, Norma B. Romero, B. Eymard, J. Beckmann, Ketty Schwartz, Danielle Château, Fernando Tomé, Kevin P. Campbell and Denis Duboc. Their work appears in journals such as Nature, New England Journal of Medicine and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact